Drug Profile
Calcitonin oral - Provalis
Alternative Names: Macritonin; Salcatonin oral - ProvalisLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Provalis
- Class Antihypercalcaemics; Calcium regulators; Neuropeptides; Osteoporosis therapies; Peptide hormones
- Mechanism of Action Calcitonin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 24 Jun 1999 Discontinued-III for Postmenopausal osteoporosis in Denmark (PO)
- 24 Jun 1999 Discontinued-III for Postmenopausal osteoporosis in United Kingdom (PO)
- 24 Jun 1999 Discontinued-preregistration for Postmenopausal osteoporosis in Austria (PO)